Daybreak

Daybreak is a direct-to-consumer sleep health company that specializes in at-home testing and treatment for obstructive sleep apnea (OSA). The company aims to make sleep apnea diagnosis and treatment more accessible by offering a convenient alternative to traditional in-lab sleep studies. Daybreak's services include a two-night at-home sleep test, which boasts a 98% accuracy rate compared to conventional diagnostics, followed by a clinical review and diagnosis by a licensed physician. In addition to testing, Daybreak facilitates the initiation of appropriate sleep apnea treatments, such as CPAP therapy. The company supports customers with insurance coverage and allows the use of FSA or HSA funds for payment. Daybreak's proprietary testing hardware is designed for home use and comes with a three-year guarantee, emphasizing durability and quality. Their digital platform streamlines the process of ordering tests, managing results, and coordinating care, providing a fully remote diagnostic experience for individuals seeking help with sleep apnea.